title: Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions.
abstract: We have shown that over-expression of human tau (0N3R) in Drosophila larval motor neurons causes significant morphological and functional disruption to the neuromuscular junctions (NMJs). Tau-expressing NMJs are reduced in size with irregular and abnormal bouton structure. Immunocytochemical analysis shows that the abnormal NMJs still retain synaptotagmin expression and form active zones. Functionally, the NMJs exhibit abnormal endo/exocytosis as revealed by incorporation of the styryl dye FM1-43. Electrophysiological studies showed that with low frequency stimulation (1 Hz), evoked synaptic potentials produced from tau over-expressing motor neurons were indistinguishable from wild type, however, following high frequency stimulation (50 Hz), evoked synaptic potentials were significantly decreased. Analysis of the number and distribution of mitochondria showed that motor neurons over-expressing tau had a significant reduction in functional mitochondria in the presynaptic terminal. Collapsing the mitochondrial membrane potential in wild type larvae phenocopied the effects of tau over-expression on synaptic transmission. Our results demonstrate that tau over-expression in vivo cause a synaptic dysfunction, which may be caused by a reduced complement of functional mitochondria.
authors: School of Biological Sciences, University of Southampton, Bassett Crescent East Southampton, SO16 7PX, UK. fcc@soton.ac.uk
authors: Francis C
authors: FC
authors: Chee
authors: Amritpal
authors: A
authors: Mudher
authors: Matthew F
authors: MF
authors: Cuttle
authors: Tracey A
authors: TA
authors: Newman
authors: Daniel
authors: D
authors: MacKay
authors: Simon
authors: S
authors: Lovestone
authors: David
authors: D
authors: Shepherd
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000494:pharmacology; D019069:Cell Respiration / Q000187:drug effects / Q000235:genetics; D004195:Disease Models, Animal; D004330:Drosophila; D004558:Electric Stimulation; D019706:Excitatory Postsynaptic Potentials / Q000235:genetics; D005089:Exocytosis / Q000235:genetics; D049452:Green Fluorescent Proteins; D006801:Humans; D007814:Larva; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009046:Motor Neurons / Q000378:metabolism / Q000473:pathology; D009154:Mutation / Q000235:genetics; D009469:Neuromuscular Junction / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D020511:Neuromuscular Junction Diseases / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D017729:Presynaptic Terminals / Q000378:metabolism / Q000473:pathology; D009435:Synaptic Transmission / Q000235:genetics*; D050863:Synaptotagmin I / Q000378:metabolism; D024801:Tauopathies / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D016875:tau Proteins / Q000235:genetics*
chemical_list: D050863:Synaptotagmin I; C485192:green fluorescent protein, Aequorea victoria; D016875:tau Proteins; D049452:Green Fluorescent Proteins; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone